Summary
In a significant market movement during March 2012, Abingdon Health was the subject of a vc funding. The transaction achieved a gross valuation of £3,000,000. Leading the round was Imperial Innovations Limited.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Imperial Innovations Limited
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedMore from Imperial Innovations Limited
Original Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in